Two Sigma Investments, LP Kronos Bio, Inc. Transaction History
Two Sigma Investments, LP
- $41.1 Billion
- Q2 2024
A detailed history of Two Sigma Investments, LP transactions in Kronos Bio, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 81,380 shares of KRON stock, worth $76,497. This represents 0.0% of its overall portfolio holdings.
Number of Shares
81,380
Previous 132,320
38.5%
Holding current value
$76,497
Previous $172,000
41.86%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding KRON
# of Institutions
59Shares Held
20.7MCall Options Held
31.4KPut Options Held
0-
Vida Ventures Advisors, LLC2.77MShares$2.6 Million3.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.92MShares$1.81 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.86MShares$1.75 Million0.0% of portfolio
-
Partners Capital Investment Group, LLP Boston, MA1.67MShares$1.57 Million0.04% of portfolio
-
Alphabet Inc. Mountain View, CA1.44MShares$1.35 Million0.11% of portfolio
About Kronos Bio, Inc.
- Ticker KRON
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,769,100
- Market Cap $53.4M
- Description
- Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...